Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

The LXR-idol axis differentially regulates plasma LDL levels in primates and mice

  • Cynthia Hong
  • , Stephanie M. Marshall
  • , Allison L. McDaniel
  • , Mark Graham
  • , Joseph D. Layne
  • , Lei Cai
  • , Elena Scotti
  • , Rima Boyadjian
  • , Jason Kim
  • , Brian T. Chamberlain
  • , Rajendra K. Tangirala
  • , Michael E. Jung
  • , Loren Fong
  • , Richard Lee
  • , Stephen G. Young
  • , Ryan E. Temel
  • , Peter Tontonoz

Producción científica: Articlerevisión exhaustiva

83 Citas (Scopus)

Resumen

The LXR-regulated E3 ubiquitin ligase IDOL controls LDLR receptor stability independent of SREBP and PCSK9, but its relevance to plasma lipid levels is unknown. Here we demonstrate that the effects of the LXR-IDOL axis are both tissue and species specific. In mice, LXR agonist induces Idol transcript levels in peripheral tissues but not in liver, and does not change plasma LDL levels. Accordingly, Idol-deficient mice exhibit elevated LDLR protein levels in peripheral tissues, but not in the liver. By contrast, LXR activation in cynomolgus monkeys induces hepatic IDOL expression, reduces LDLR protein levels, and raises plasma LDL levels. Knockdown of IDOL in monkeys with an antisense oligonucleotide blunts the effect of LXR agonist on LDL levels. These results implicate IDOL as a modulator of plasma lipid levels in primates and support further investigation into IDOL inhibition as a potential strategy for LDL lowering in humans.

Idioma originalEnglish
Páginas (desde-hasta)910-918
Número de páginas9
PublicaciónCell Metabolism
Volumen20
N.º5
DOI
EstadoPublished - nov 4 2014

Nota bibliográfica

Publisher Copyright:
© 2014 Elsevier Inc.

Financiación

We are grateful for the technical contributions of Kathryn L. Kelley and Janet K. Sawyer at Wake Forest University School of Medicine, Jon Salazar at UCLA, and Matthew Hallowell from Tulane University. This work was supported by NIH grants HL088528 and HL111932 (R.E.T.), HL066088 (P.T.), and HL090553 (S.G.Y. and P.T.) and by ADA grant 1-14-JF-33 (C.H.). P.T. in an Investigator of the Howard Hughes Medical Institute.

FinanciadoresNúmero del financiador
National Institutes of Health (NIH)HL090553, HL066088, HL111932
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)R00HL088528
National Heart, Lung, and Blood Institute (NHLBI)
Aeronautical Development Agency India1-14-JF-33
Aeronautical Development Agency India

    ASJC Scopus subject areas

    • Physiology
    • Molecular Biology
    • Cell Biology

    Huella

    Profundice en los temas de investigación de 'The LXR-idol axis differentially regulates plasma LDL levels in primates and mice'. En conjunto forman una huella única.

    Citar esto